As artificial intelligence becomes more embedded in clinical development, the focus is shifting from capability to trust. At ...

Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing, dual sourcing and networked CDMO capacity ...

OXB has signed an agreement with Plowshare Therapies, a biotechnology company developing gene therapies for rare genetic ...

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, has entered a multi-target strategic ...

Bora Pharmaceuticals has completed its acquisition of MacroGenics, Inc.’s GMP manufacturing operations, including its ...

What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...

Henny Zijlstra, Chief Commercial Officer of Ardena, discusses the integrated CDMO model, Ardena’s new laboratory in New ...

AdvanCell, a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, has closed an ...

EpilepsyGTx, a biotechnology company, and ClearPoint Neuro, a global therapy-enabling company offering precise navigation and ...

OneSource Specialty Pharma Limited and Formycon AG have entered a strategic manufacturing partnership for biosimilars.

BriaCell Therapeutics Corp. has entered into a manufacturing arrangement with FUJIFILM Biotechnologies California to support ...

Editor’s Take: The companies hope their partnership is a gamechanger in accelerating AI-driven antibody design. Gandeeva Therapeutics and Zymeworks are partnering on cryo-electron microscopy (cryo-EM) ...